Presence and Relevance of Myocardial Bridge in LAD-PCI of CTO and Non-CTO Lesions

Kei Yamamoto1, Yoichiro Sugizaki1, Dimitri Karmpaliotis2

  • 1Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York, USA; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA.

PubMed
Abstract

Insights

Myocardial bridges (MB) are more common in left anterior descending (LAD) chronic total occlusions (CTOs). Stenting into an MB in LAD CTOs significantly increases the risk of target lesion failure.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Ultrasound

Background:

  • Myocardial bridges (MB) are found in approximately 25% of left anterior descending (LAD) arteries.
  • Stent failure is a concern when stents are placed within an MB in the LAD artery.

Purpose of the Study:

  • To determine the association between MB and LAD chronic total occlusions (CTOs).
  • To evaluate the impact of MB on clinical outcomes after percutaneous coronary intervention (PCI) in LAD CTOs.

Main Methods:

  • Analysis of 3,342 LAD lesions undergoing IVUS-guided PCI, including 280 CTOs.
  • Primary outcome: target lesion failure (cardiac death, MI, stent thrombosis, revascularization).

Main Results:

  • MB prevalence was higher in LAD CTOs (40.4%) than non-CTOs (25.8%).
  • Discrepancy in CTO length between angiography and IVUS was greater with MB.
  • Target lesion failure was significantly higher (26.3%) when stents extended into MB in LAD CTOs compared to those without MB (9.6%).

Conclusions:

  • Myocardial bridges are more prevalent in LAD CTOs compared to non-CTOs.
  • Approximately half of LAD CTOs with MB had stents extending into the bridge, leading to worse clinical outcomes.

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...